GlassScriptPhysician profile
John Pettit
NPI 1407937253
$5,070.58
in general payments reported to CMS, 2019-2025
47 companies · $911 in 2025
The $911 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $776 · 2020: $407 · 2021: $24.00 · 2022: $472 · 2023: $1,070 · 2024: $1,409 · 2025: $911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,374 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,374.12 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $420.88 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $406.59 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $371.23 | 2023-2025 | Gemtesa |
| Neotract INC. | $353.46 | 2019-2020 | |
| Astellas Pharma US INC | $271.59 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $232.31 | 2019-2024 | |
| Pfizer INC. | $219.03 | 2019-2025 | |
| Accord Healthcare, INC. | $217.29 | 2023-2025 | |
| Medtronic USA, INC. | $212.32 | 2019-2020 | |
| Immunitybio, INC. | $190.73 | 2024-2025 | |
| Antares Pharma, INC. | $181.76 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $135.42 | 2019-2024 | Aveed, Xiaflex |
| Valencia Technologies Corporation | $131.42 | 2025 | Ecoin Device Kit |
| Merck Sharp & Dohme LLC | $130.83 | 2023-2025 | Keytruda, Zerbaxa, Lynparza |
| C. R. Bard, INC. & Subsidiaries | $127.86 | 2023-2024 | Bard Urinary Drainage Bag |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pettit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.